It will be the older, less expensive drugs that help pharmaceutical companies succeed in emerging markets such as China, India, Russia and Brazil, where the ability to purchase health care is on the rise but with an emphasis on lower-cost medications, according to IMS.
While the global market is increasing about 6% per year, in emerging markets the rate is in double digits, giving these areas more importance in pharmaceutical sales strategies, IMS says.

Related Summaries